期刊文献+

Notch1信号通路与白藜芦醇抗急性T淋巴细胞白血病作用机制研究进展 被引量:1

下载PDF
导出
摘要 急性T淋巴细胞白血病(T-ALL)是一类预后不良的恶性淋巴细胞增殖性疾病。T-ALL的发生与Notch1及其介导的信号通路密切相关。Hes-1基因是Notch1的靶基因,被激活后通过PTEN/PI3K/Akt/mTOR信号通路抑制抑癌基因p53表达阻止细胞凋亡,诱导T-ALL发生。白藜芦醇(Res)是一种具有化学防癌作用的多酚类植物抗生素。Res对T-ALL Molt-4细胞具有抑制增殖、诱导凋亡的作用。但Res是否通过Notch1通路发挥作用及其机制尚不十分清楚。本文就Notch1信号通路与T-ALL的发生、治疗以及Notch1信号通路与白藜芦醇抗T-ALL作用机制的研究现状作一综述。
出处 《临床检验杂志》 CAS CSCD 北大核心 2012年第10期799-802,共4页 Chinese Journal of Clinical Laboratory Science
  • 相关文献

参考文献30

  • 1Sarmento LM, Barata JT. Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises[J]. Expert Rev Anticancer Ther, 2011, 11(9) :1403-1415.
  • 2Tsan MF, White JE, Maheshwari JG, et al. Anti-leukemia effect of resveratrol[J]. Leuk Lymphoma, 2002, 43 (5) :983-987.
  • 3Lee SK, Zhang W, Sanderson BJ. Selective growth inhibition of hu- man leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction[ J]. J Agric Food Chem, 2008, 56(16) :7572-7577.
  • 4Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T celt acute lymphoblatic leukemia[J]. Science, 2004, 306 (5694) :269-271.
  • 5Tanigaki K, Honjo T. Regulation of lymphocyte development by Notch signaling[J]. Nat Immunol, 2007, 8 (5) :451-456.
  • 6Palomero T, Lim WK, Odom DT, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network pro- moting leukemic cell growth [ J]. Proc Nati Acad Sci USA, 2006, 103 (48) :18261-18266.
  • 7Shama VM, Draheim KM, Kelliher MA. The Notchl/c-Myc pathway in T cell leukemia [ J ]. Cell Cycle, 2007, 6 ( 8 ) :927-930.
  • 8Lin YW, Nichols RA, Letterio JJ, et al. Notchl mutations are im- portant for leukemic transformation in murine models of precursor-T leukemia/lymphoma[J]. Blood, 2006, 107(6) :2540-2543.
  • 9Sharma VM, Calvo JA, Draheim KM, et al. Notchl contributes to mouse T-cell leukemia by directly inducing the expression of c-myc[J]. Mol Cell Biol, 2006, 26(21 ):8022-8031.
  • 10Weng AP, Millholland JM, Yashiro-Ohtani Y, et al. c-Mye is an important direct target of Notchl in T-cell acute lymphoblastic leu- kemia/lymphoma[ J]. Genes Dev, 2006, 20(15) :2096-2109.

二级参考文献35

  • 1牛培勤,郭传勇.白藜芦醇药理作用的研究进展[J].医药导报,2006,25(6):524-525. 被引量:79
  • 2温志震,于宝海,魏虎来,苏海翔,郝春燕.白藜芦醇诱导K562细胞凋亡过程中Bcl-2蛋白水平的改变[J].中国临床药理学与治疗学,2006,11(4):421-423. 被引量:4
  • 3Kojic EM ,Darouiche RO. Candida infections of medi- cal devices[J]. Clin Microbiol Rev, 2004,17 (2) : 255- 267.
  • 4Hall-stoodley L,Costerton JW,Stoodley P. Bacterial biofilms:from the natural environment to infectious diseases[J]. Nat Rev Microtn'ol,2004,2 (2) :95-108.
  • 5Mukherjee PK ,Mohamed S,Chandra J,et al. Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter sur- faces through an ethanol-based mechanism[J]. Infect lrnmum, 2006,74 (7) : 3804-3816.
  • 6Romero R,Schaudinn C,Kusanovic JP,et al. Detec- tion of a microbial biofilm in intraamniotic infection [J]. Am J Obstet Crynecol, 2008, 198 (1): 135el- 135e5.
  • 7Ramage G,Vande Wallek K ,Wickesb BL,et al. Stan- dardized method for in vitro antifungal susceptibility testing of Candida altn'cans biofilms [J]. Antimicrob Agents Chemother,2001,45(9) :2475-2479.
  • 8Cao YY,Dai BD,Wang Y,et al. In vitro activity of baicalein against Candida albicans biofilms[J]. Int J Antimicrob Agents, 2008,32 (1) : 73-77.
  • 9Miao He, Minquan Du, Mingwen Fan, et al. In vitro activity of eugenol against Candida albicans biofilms [J]. Mycopathologia, 2007,163 (3) : 137-143.
  • 10Lopez-Ribot JL. Candida altn-cans biofilms :more th- an filamentation [J]. Curt Biol, 2005, 15 (12) : 453- 455.

共引文献39

同被引文献23

  • 1Wang G, Dai F, Yu K, et al. Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways [ J ]. Int J Oncol, 2015, 46: 1739-1747.
  • 2A1-Ahd AM, Mahmoud AM, E1-Sherbiny GA, et al. Res- veratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro [ J ]. Cell Prolif, 2011, 44: 591-601.
  • 3Berginc K, Kristl A. The mechanisms responsible for gar- lic-drag interactions and their in vivo relevance [ J ]. Curr Drug Metab, 2013, 14 : 90-101.
  • 4Huang F, Wu XN, Chen J, et al. Resveratrol reverses mul- tidrug resistance in human breast cancer doxorubicin-resist- ant cells [J]. Exp Ther Med, 2014, 7: 1611-1616.
  • 5Quan F, Pan C, Ma Q, et al. Reversal effect of resveratrol on multidrug resistance in KBv200 cell line [ J ]. Biomed Pharmacother, 2008, 62: 622-629.
  • 6Kim JH, Chen C, Tony KAN. Resveratrol inhibits genistein-induced muhi-drug resistance protein 2 (MRP2) expression in HepG2 cells [ J ]. Arch Biochem Biophys, 2011, 512: 160-166.
  • 7Kim TH, Shin YJ, Won AJ, et al. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer ceils via increased cellular influx of doxorubi- cin [J]. Biochim Biophys Acta, 2014, 1840: 615-625.
  • 8Natarajan K, Xie Y, Baer MR, et al. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resist- ance [J]. Biochem Pharmacol, 2012, 83: 1084-1103.
  • 9Sugimoto Y, Tsukahara S, Imai Y, et al. Reversal of breast cancer resistance protein-mediated drug resistance by estro- gen antagonists and agonists [J]. Mol Cancer Ther, 2003, 2: 105-112.
  • 10Imai Y, Yamagishi H, Ono Y, et al. Versatile inhibitory effects of the flavonoid-derived PI3K/AKT inhibitor, LY294002, on ATP-binding cassette transporters that characterize stem cells [J]. Clin Transl Med, 2012, 1 : 24-30.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部